Wednesday, March 11, 2009 11:15:22 AM
Just to be clear, you see this as a ridiculous bottom with a clear indication to buy. If the upside was so large and the risks so futile, why then would you not see some buyers from the well informed...people that know the Dr.'s, that know the molecules, that understand the case studies, etc. I can understand the street giving up on Cor, but with all the money sitting on the sidelines and many individuals fairly well off, such as Dr's of the neuro trade, with available cash aware of Cor's potential, again why are we not seeing more buyers of the stock at these levels? If you belive in your scenario, as I am sure you do, then you and your family and friends, and your family's families and friends, and their family's families and friends, should be buying shares right now, not to mention the families and friends of the lab rats and scientists that are well aware of the abilities and potential of ampakines. Something just smells bad here. Just give us the buyout, put the molecules in more capable hands, and let the endlessly suffering investors recoupe some of their overly persistant and patient dollars they so eagerly put into the promise of ampakines. The story feels over. $5-$6 upside seems a fantasy. Dilution at these levels a travesty.
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM